Structures by: Scholtzová E.
Total: 8
(1-Methylimidazole)(N-salicylidene-rac-glutamato)copper(II)
C16H17CuN3O5
Acta Crystallographica Section E (2003) 59, 12 m1181-m1183
a=7.92940(10)Å b=11.33050(10)Å c=18.53870(10)Å
α=90.00° β=98.7070(10)° γ=90.00°
(N-Salicylidene-DL-glutamato)(2-methylimidazole)copper(II)
C16H17CuN3O5
Acta Crystallographica Section E (2004) 60, 1 m129-m132
a=5.23190(10)Å b=16.2576(3)Å c=9.60440(10)Å
α=90.00° β=96.5300(10)° γ=90.00°
3-(4-Bromophenyl)-5-(4-dimethylaminophenyl)-1-phenyl-2-pyrazoline
C23H22BrN3
Acta Crystallographica Section C (2007) 63, 6 o340-o342
a=32.3762(4)Å b=43.4056(2)Å c=5.56180(10)Å
α=90.00° β=90.00° γ=90.00°
Anti-2-Hydroxy-2-methyl-1-tetralone oxime
C11H13NO2
Acta Crystallographica Section C (2006) 62, 4 o199-o202
a=7.3655(2)Å b=9.6851(2)Å c=14.47200(10)Å
α=93.3750(10)° β=99.4760(10)° γ=102.2880(10)°
2-(4-hydroxyphenyl)-4,4-dimethyl-2-oxazoline
C11H13NO2
Acta Crystallographica Section C (2006) 62, 7 o416-o418
a=12.1590(2)Å b=8.56660(10)Å c=9.99990(10)Å
α=90.00° β=90.00° γ=90.00°
2-Anilinomethylene-3-oxobutanenitrile
C11H10N2O
Acta Crystallographica Section C (2006) 62, 9 o544-o546
a=13.3968(5)Å b=5.0656(2)Å c=14.3402(5)Å
α=90.00° β=108.0270(10)° γ=90.00°
(E)-Methyl 2-anilinomethylene-3-oxobutanoate
C12H13NO3
Acta Crystallographica Section C (2007) 63, 9 o552-o554
a=5.3812(3)Å b=9.9032(6)Å c=20.1882(12)Å
α=90.00° β=90.00° γ=90.00°
2-(2,5-dihydroxyphenyl)-2-oxazoline
C9H9NO3
Acta Crystallographica Section C (2007) 63, 3 o187-o189
a=24.4297(3)Å b=31.7167(7)Å c=4.44090(10)Å
α=90.00° β=90.00° γ=90.00°